Finist
IMPORTERS DIRECT WHOLESALE CO., INC. — GLENDALE, CA
Estonia
About Finist
Finist is a vodka brand originating from Estonia. The spirit is bottled at a proof level between 80 and 89, placing it within the standard vodka category as defined by spirits regulations. According to TTB records, Finist received its first label approval in 2023, marking its entry into the United States market. The brand maintains a single product offering within its portfolio on retail platforms. As an Estonian vodka, Finist represents the Eastern European vodka tradition, a region with a long-established heritage in spirits production. The brand's TTB classification as a standard vodka indicates it meets the regulatory requirements for the category without specialized designations or age statements. With its recent approval and single distinct product line, Finist represents a focused market entry for consumers seeking vodka options from the Baltic region.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
| Finist Supreme Vodka VODKA 80-89 PROOF FB | Vodka 80-89 Proof Fb | Approved | 2023-05-04 | IMPORTERS DIRECT WHOLESALE CO., INC. |
Page 1 of 1
Finist at a Glance
Finist has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof Fb. Labels approved between 2023-05-04 and 2023-05-04. Produced in Estonia.
All information sourced from public TTB records.
Are you the owner or distributor of Finist?
Claim this brand listing to update information or get featured. Contact team@buy.vodka.
Produced At
Importers Direct Wholesale CO., INC.Related Brands
- St Petersburg Heritage also from Estonia
- Barin also from Estonia
- Freimeister Kollektiv also from Estonia
- Goodnoff also from Estonia
- J.J Kurberg also from Estonia
- Svedka also makes Vodka 80-89 Proof Fb
- Stoli also makes Vodka 80-89 Proof Fb
- Stolichnaya also makes Vodka 80-89 Proof Fb
- Van Gogh also makes Vodka 80-89 Proof Fb
- Beluga also makes Vodka 80-89 Proof Fb
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.